Try one of the below options to narrow down your search.
 |
Documents may be browsed by date, eg; Today, June, 2013.
Past years can be browsed too, eg; 2012, 2011, 2010, 2009 ...
Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg; Media releases from 2013
Document tags (shown below the document date, eg; Schedule, SAForms, consultation ...) have highest priority when search results are ranked, followed by title, abstract and full text of document.
Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.
Remember to group or statements with parentheses if they are beside and statements.
Search examples
- consultation
- Search for consultations
- media and not antibiotics
- Search for media related documents that don't mention antibiotics.
- (media or consultation) and vaccines
- Search for media releases and consultation documents mentioning vaccinations.
Search term: consultation
2011
PHARMAC documents that matched your search:
Proposal relating to risperidone and quetiapine; Closing Date: Closed; Contact: Geraldine MacGibbon
(2 pages, 115 KB)
2011/09/23
23 September 2011 Proposal to re-apply reference pricing across brands of risperidone and quetiapine PHARMAC is seeking feedback on a proposal to re-apply reference pricing across different brands of risperidone tablets and oral liquid and across different brands of quetiapine…
Consultation on provisional agreement with CSL Biotherapies; Closing Date: Closed; Contact: Greg Williams
(3 pages, 133 KB)
2011/09/22
22 September 2011 Proposal relating to betamethasone diproprionate with calcipotriol, calcipotriol, fusidic acid and bumetanide. PHARMAC is seeking feedback on a proposal to fund betamethasone diproprionate with calcipotriol (Daivobet) through a provisional agreement with CSL Biotherapies (NZ) Limited. This proposal…
Proposal to amend the terms of listing for efavirenz; Closing Date: Closed; Contact: Greg Williams
(1 page, 110 KB)
2011/09/22
22 September 2011 Proposal to amend the terms of listing for efavirenz Following a request to pharmaceutical suppliers for commercial proposals as an alternative to tendering certain pharmaceuticals for sole supply, PHARMAC and Merck Sharp and Dohme (New Zealand) Limited…
Proposal relating to four opthalmological products; Closing Date: Closed; Contact: Sue Anne Yee
(2 pages, 125 KB)
2011/09/14
14 September 2011 Proposal relating to bimatoprost, brimonidine tartrate with timolol maleate and prednisolone acetate PHARMAC is seeking feedback on a proposal relating to a provisional agreement with Allergan Australia Pty Ltd for four ophthalmological products. In summary, this proposal…
Proposal on subsidy changes and access for some respiratory products; Closing Date: Closed; Contact: Christine Chapman
(5 pages, 149 KB)
2011/08/30
30 August 2011 Proposal on subsidy changes for some respiratory inhalation products and access restrictions to combination inhalers. As notified on 16 June 2011, PHARMAC has been considering options for managing the funding of the inhaled corticosteroids (ICS) and long-acting…
Proposal to amend General Rules in the Pharmaceutical Schedule; Closing Date: Closed; Contact: Rebecca Bloor
(6 pages, 145 KB)
2011/08/19
19 August 2011 Proposal to amend the General Rules in the Pharmaceutical Schedule PHARMAC is seeking feedback on a proposal to amend the General Rules in the Pharmaceutical Schedule. The intention of this proposal is to reduce some of the…
Proposal to remove the pravastatin Special Authority restriction; Closing Date: Closed; Contact: Sue Anne Yee
(1 page, 76 KB)
2011/08/12
12 August 2011 Proposal to remove the pravastatin Special Authority restriction PHARMAC is seeking feedback on a proposal to remove the Special Authority restriction currently applying to pravastatin from 1 November 2011. Further details of the proposal can be found…
Proposal to amend special authorities for trastuzumab (Herceptin) and sunitinib (Sutent); Closing Date: Closed; Contact: Jackie Evans
(3 pages, 131 KB)
2011/08/02
2 August 2011 Proposal to Amend Special Authorities for trastuzumab (Herceptin) and sunitinib (Sutent) PHARMAC is seeking feedback on a proposal to make minor amendments to the Special Authority criteria applying to trastuzumab and sunitinib from 1 October 2011. The…
Proposal to list Dr Reddy's brand of atorvastatin; Closing Date: Closed; Contact: Sue Anne Yee
(2 pages, 107 KB)
2011/07/29
29 July 2011 Proposal to list Dr Reddy’s brand of atorvastatin PHARMAC is seeking feedback on a proposal to fund a new brand of atorvastatin tablets (Dr Reddy’s Atorvastatin) from 1 November 2011 through a provisional agreement with Dr Reddy’s…
Proposal for early processing of new Special Authority forms; Closing Date: Closed; Contact: Rachel Mackay
(1 page, 108 KB)
2011/07/26
26 July 2011 Proposal for early processing of new Special Authority forms PHARMAC is seeking feedback on a proposal to commence processing new Special Authority forms three business days prior to the first date on which any approvals would become…
